Saturday, January 14, 2017 8:31:36 AM
http://pitchbook.com/profiles/novotyr-therapeutics-profile-investors-funding-valuation-and-analysis
Details
http://www.firstwordpharma.com/node/29233?tsid=17#axzz4VjzLPNqB
- Teva invested $1 million in Novotyr Therapeutics and has an option to invest several million dollars more for a 27 percent stake in the company, Globes online reported today.
- Novotyr is developing inhibitors of an insulin-like growth factor receptor as drugs for the treatment of cancer and other diseases. The company plans to begin clinical trials in 2009.
Novotyr was the previously name of Tyrnovo.
Still have to do some DD about, but looks like there is Teva behind Novotyr and his illuminated co-founder Alexander Levitzki (where he served ad Member of Scientific Advisory Board).
http://www.bloomberg.com/research/stocks/people/person.asp?personId=6313122&capId=6313094&previousCapId=6700309&previousTitle=United%20States%20Department%20Of%20Agriculture
Waiting for PR where Management can explain this new strategy.
Avant Technologies Equipping AI-Managed Data Center with High Performance Computing Systems • AVAI • May 10, 2024 8:00 AM
VAYK Discloses Strategic Conversation on Potential Acquisition of $4 Million Home Service Business • VAYK • May 9, 2024 9:00 AM
Bantec's Howco Awarded $4.19 Million Dollar U.S. Department of Defense Contract • BANT • May 8, 2024 10:00 AM
Element79 Gold Corp Successfully Closes Maverick Springs Option Agreement • ELEM • May 8, 2024 9:05 AM
Kona Gold Beverages, Inc. Achieves April Revenues Exceeding $586,000 • KGKG • May 8, 2024 8:30 AM
Epazz plans to spin off Galaxy Batteries Inc. • EPAZ • May 8, 2024 7:05 AM